351 related articles for article (PubMed ID: 27144061)
21. Acute myeloid leukemia: 2013 update on risk-stratification and management.
Estey EH
Am J Hematol; 2013 Apr; 88(4):318-27. PubMed ID: 23526416
[TBL] [Abstract][Full Text] [Related]
22. Perspective on how to approach molecular diagnostics in acute myeloid leukemia and myelodysplastic syndromes in the era of next-generation sequencing.
Kohlmann A; Bacher U; Schnittger S; Haferlach T
Leuk Lymphoma; 2014 Aug; 55(8):1725-34. PubMed ID: 24144312
[TBL] [Abstract][Full Text] [Related]
23. Next generation sequencing of acute myeloid leukemia: influencing prognosis.
Ilyas AM; Ahmad S; Faheem M; Naseer MI; Kumosani TA; Al-Qahtani MH; Gari M; Ahmed F
BMC Genomics; 2015; 16 Suppl 1(Suppl 1):S5. PubMed ID: 25924101
[TBL] [Abstract][Full Text] [Related]
24. [Molecular Genetic Testing for Acute Myeloid Leukemia].
Janečková V; Semerád L; Ježíšková I; Dvořáková D; Čulen M; Šustková Z; Mayer J; Ráčil Z
Klin Onkol; 2016; 29(6):411-418. PubMed ID: 27951719
[TBL] [Abstract][Full Text] [Related]
25. Diagnostic, Prognostic, and Predictive Utility of Recurrent Somatic Mutations in Myeloid Neoplasms.
Patel U; Luthra R; Medeiros LJ; Patel KP
Clin Lymphoma Myeloma Leuk; 2017 Jul; 17S():S62-S74. PubMed ID: 28760304
[TBL] [Abstract][Full Text] [Related]
26. Cytogenetics in acute myeloid leukemia.
Schoch C; Haferlach T
Curr Oncol Rep; 2002 Sep; 4(5):390-7. PubMed ID: 12162912
[TBL] [Abstract][Full Text] [Related]
27. Controversies in the recent (2016) World Health Organization classification of acute myeloid leukemia.
Hasserjian RP
Best Pract Res Clin Haematol; 2021 Mar; 34(1):101249. PubMed ID: 33762104
[TBL] [Abstract][Full Text] [Related]
28. Importance of assessing cytogenetic and molecular risk factors in acute myeloid leukemia therapy.
Coles EC; Colita A; Momanu R; Berbec N; Ivanescu AM; Oprea M; Jardan D; Jardan C; Arghir A; Coriu D; Lupu AR
J Med Life; 2012; 5(Spec Issue):36-43. PubMed ID: 31803284
[TBL] [Abstract][Full Text] [Related]
29. The utility of next-generation sequencing in diagnosis and monitoring of acute myeloid leukemia and myelodysplastic syndromes.
Duncavage EJ; Tandon B
Int J Lab Hematol; 2015 May; 37 Suppl 1():115-21. PubMed ID: 25976969
[TBL] [Abstract][Full Text] [Related]
30. Mutations in AML: prognostic and therapeutic implications.
DiNardo CD; Cortes JE
Hematology Am Soc Hematol Educ Program; 2016 Dec; 2016(1):348-355. PubMed ID: 27913501
[TBL] [Abstract][Full Text] [Related]
31. Validation of risk stratification models in acute myeloid leukemia using sequencing-based molecular profiling.
Wang M; Lindberg J; Klevebring D; Nilsson C; Mer AS; Rantalainen M; Lehmann S; Grönberg H
Leukemia; 2017 Oct; 31(10):2029-2036. PubMed ID: 28167833
[TBL] [Abstract][Full Text] [Related]
32. Genetic Landscape of Acute Myeloid Leukemia Interrogated by Next-generation Sequencing: A Large Cancer Center Experience.
Hussaini MO; Mirza AS; Komrokji R; Lancet J; Padron E; Song J
Cancer Genomics Proteomics; 2018; 15(2):121-126. PubMed ID: 29496691
[TBL] [Abstract][Full Text] [Related]
33. Next Generation Sequencing in AML-On the Way to Becoming a New Standard for Treatment Initiation and/or Modulation?
Leisch M; Jansko B; Zaborsky N; Greil R; Pleyer L
Cancers (Basel); 2019 Feb; 11(2):. PubMed ID: 30795628
[TBL] [Abstract][Full Text] [Related]
34. Genomics of Acute Myeloid Leukemia Diagnosis and Pathways.
Bullinger L; Döhner K; Döhner H
J Clin Oncol; 2017 Mar; 35(9):934-946. PubMed ID: 28297624
[TBL] [Abstract][Full Text] [Related]
35. Molecular Malfeasance Mediating Myeloid Malignancies: The Genetics of Acute Myeloid Leukemia.
King RL; Bagg A
Methods Mol Biol; 2017; 1633():1-17. PubMed ID: 28735477
[TBL] [Abstract][Full Text] [Related]
36. Genomic, immunophenotypic, and NPM1/FLT3 mutational studies on 17 patients with normal karyotype acute myeloid leukemia (AML) followed by aberrant karyotype AML at relapse.
Wang ES; Sait SN; Gold D; Mashtare T; Starostik P; Ford LA; Wetzler M; Nowak NJ; Deeb G
Cancer Genet Cytogenet; 2010 Oct; 202(2):101-7. PubMed ID: 20875872
[TBL] [Abstract][Full Text] [Related]
37. Acute myeloid leukemia: conventional cytogenetics, FISH, and moleculocentric methodologies.
Morrissette JJ; Bagg A
Clin Lab Med; 2011 Dec; 31(4):659-86, x. PubMed ID: 22118743
[TBL] [Abstract][Full Text] [Related]
38. Clinical implications of recurrent gene mutations in acute myeloid leukemia.
Yu J; Li Y; Zhang D; Wan D; Jiang Z
Exp Hematol Oncol; 2020; 9():4. PubMed ID: 32231866
[TBL] [Abstract][Full Text] [Related]
39. The 2016 WHO classification of acute myeloid leukemia: What the practicing clinician needs to know.
Arber DA
Semin Hematol; 2019 Apr; 56(2):90-95. PubMed ID: 30926096
[TBL] [Abstract][Full Text] [Related]
40. A three-gene expression-based risk score can refine the European LeukemiaNet AML classification.
Wilop S; Chou WC; Jost E; Crysandt M; Panse J; Chuang MK; Brümmendorf TH; Wagner W; Tien HF; Kharabi Masouleh B
J Hematol Oncol; 2016 Sep; 9(1):78. PubMed ID: 27585840
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]